SEHK:6855Biotechs
Ascentage Pharma Group International (SEHK:6855) Adds Global Dealmakers As Fair Value Debate Builds
The appointment of Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer gives Ascentage Pharma Group International (SEHK:6855) dedicated leadership for global business development and ex-China commercialization.
See our latest analysis for Ascentage Pharma Group International.
Ascentage Pharma Group International’s recent executive appointments come as the stock shows a mixed picture, with the 7 day share price return of 7.81% and 30 day share price return of...